← Eichor
Study identifier: NCT05550064 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Structured Contraceptive Counseling During Pregnancy

Condition: Contraception · Intrauterine Device · Contraceptive Implant  ·  Sponsor: Dalarna University

PhaseNA
Planned participants160
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersYes

About this study

Unintended pregnancy is common among women of fertile age, and also among those who have recently given birth. A Swedish study has shown that about 7.7% experience a new pregnancy, and that 2.5% will have an abortion between 12-24 months from childbirth. This is a prospective observational intervention study, aiming to evaluate the effects of structured contraceptive counseling during pregnancy on uptake of contraception postpartum and more specifically on long-acting reversible contraceptive methods, and to identify and explore the provider's and patient's experiences of structured contraceptive counseling during pregnancy.

This description comes directly from the study's public registry record.

Talk to the study team

Niklas Envall, PhD  ·  +46704090925  ·  nen@du.se

Always discuss trial participation with your own doctor first.

Locations (4)

Health Care Region DalarnaFalun, SwedenRecruiting
Health Care Region VärmlandKarlstad, SwedenRecruiting
Health Care Region Örebro LänÖrebro, SwedenRecruiting
Health Care Region UppsalaUppsala, SwedenRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05550064